PharmaTher Holdings Ltd. (OTC:PHRRF – Get Rating)'s stock price shot up 12% on Wednesday . The stock traded as high as $0.13 and last traded at $0.12. 139,111 shares traded hands during mid-day trading, a decline of 24% from the average session volume of 181,993 shares. The stock had previously closed at $0.11.
PharmaTher Stock Up 12.0 %
The firm has a fifty day simple moving average of $0.10 and a two-hundred day simple moving average of $0.09.
About PharmaTher
(Get Rating)
PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's product in pipeline includes Ketamine intravenous injection, which is in Phase II and III clinical trials for Parkinson's disease, anesthesia and sedation, and amyotrophic lateral sclerosis indications.
Read More
- Get a free copy of the StockNews.com research report on PharmaTher (PHRRF)
- Jack in the Box Pops On Tasty Results, Robust Outlook
- How Low Can Lowe's Companies Go?
- Ambarella: An AI Play In The Making
- Terran Orbital's New $2.4 Billion Contract is a Game Changer
- Wendy's Price Firms After Sizzling Quarter And Juicy Outlook
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.